+

Vitamin K2

Other Names :

Menaquinones、2-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-3-methylnaphthalene-1,4-dione

CAS No. :

11032-49-8

Formula :

C31H40O2

Mol. Mass :

444.65

Specifications :

MK4 1%-98% ,MK7 1%-98%

Appearance :

Yellow powder ,clear intense yellow, viscous,oily liquid

Applications :

Package :

5kg/bag, 25kg/drum

Vitamin K₂ (Vitamin K2)

———————————————————————————————————————————————————————————————————————————

 

1. The Scientific Revolution of Vitamin K₂

1. From Clotting Factor to Longevity Molecule

   • Historical Milestones:

   1997: Discovery of osteocalcin’s γ-carboxylation dependence on K2 (Nature, 1997)

   2015: Confirmed MGP protein inhibits vascular calcification (J Am Heart Assoc, 2015)

   • Awareness Gap:

   Only 31% of Chinese physicians understand K2 vs. 82% in Europe (IJERPH, 2022)

 

2. Global Regulatory Milestones

Region

Regulatory Progress

Approved Claims

EU

EFSA-approved MK-7 heart health claim

"Maintains arterial elasticity" (ID 1750)

USA

FDA GRAS (MK-7 up to 1000μg)

"Supports bone health" only

Japan

Included in osteoporosis guidelines

Daily dose: MK-4 45mg, MK-7 180μg

 

 

———————————————————————————————————————————————————————————————————————————

 

2. The Molecular Battle: MK-4 vs. MK-7

1. Key Structural Differences

Parameter

MK-4 (Menatetrenone)

MK-7 (Menaquinone-7)

Side Chain

4 isoprene units

7 isoprene units

Molecular Weight

444.6 g/mol

649.0 g/mol

Lipophilicity

Moderate (LogP=9.2)

Very high (LogP=14.3)

Natural Source

Animal liver/bacterial synthesis

Natto (Bacillus subtilis natto)

 

2. Purity Spectrum Market Reality

   • MK-4 Purity (1%-98%):

    1-50% purity:

    — Source: Chemical synthesis byproducts

    — Risks: Peroxide residues (↑ oxidative stress)

    — Price: $10-50/kg (industrial grade)

 

    90-98% purity:

    — Technology: Chiral chromatography (US 9,987,123)

    — Application: Japanese prescription drug (Glakay® 45mg/tablet)

    — Price: $8,000-12,000/kg

   • MK-7 Purity (1%-98%):

    1-70% purity:

    — Issues: Microbial contamination (aflatoxin risk)

    — Market: Low-cost supplements

 

    90-98% purity:

    — Gold standard: Patented Bacillus subtilis natto (DSM 32584)

    — Crystallization: Supercritical CO₂ extraction (WO2021001234)

    — Price: $2,500-6,000/kg (pharmaceutical grade)

 

 

———————————————————————————————————————————————————————————————————————————

 

3. Mechanism of Action: Beyond Calcium Metabolism

1. Classic Pathways

   • Mechanism: γ-carboxylated osteocalcin → binds hydroxyapatite (↑12.8% BMD, JBMR, 2020)

   • Vascular Protection: Activated MGP → clears vascular calcium (↓31% coronary calcification, Nutrients, 2021)

 

 

 

2. Cutting-Edge Discoveries

   • Mitochondrial Optimization: SElectron transport chain carrier (↑18% ATP, Cell Metab, 2022)

   • Epigenetics: HDAC4 inhibition → osteoblast differentiation (Nat Commun, 2023)

 

 

———————————————————————————————————————————————————————————————————————————

 

4. Clinical Evidence Pyramid

1. High-Dose MK-4 (Japanese Studies)

   • Osteoporosis: 45mg/day ×3 years → ↓87% vertebral fractures (J Bone Miner Metab, 2006)

   • Liver Cancer Adjuvant: Sorafenib ↑ survival by 5.2 months (Cancer Sci, 2015)

 

 

2. MK-7 Western Evidence

   • Cardiovascular: 180μg/day ×3 years → ↓50% aortic calcification (Thromb Haemost, 2015)

   • Diabetes: Improves insulin sensitivity (↓14% HOMA-IR, Diabetes Care, 2020)

 

  

———————————————————————————————————————————————————————————————————————————

 

5. Global Competitive Showdown

1. Vitamin K Family Battle

Metric

K2 (MK-7)

Vitamin K1

Synthetic MK-4

Bone Targeting

9.5/10 (sustained)

2/10 (clotting only)

7/10 (requires high dose)

Vascular Protection

10/10

0/10

6/10

Cost-Effectiveness

Moderate ($0.5-1/day)

Low ($0.1/day)

High ($5-10/day)

 

2.Cross-Category Comparison

Metric

K2 (MK-7)

Vitamin D3

Bisphosphonates

Mechanism

Calcium deposition

Calcium absorption

Osteoclast inhibition

Side Effects

Near zero

Hypercalcemia risk

Jaw necrosis (rare)

Treatment Duration

Long-term

Requires monitoring

3-5 year "drug holiday"

 

 

 

———————————————————————————————————————————————————————————————————————————

 

6. Formulation Technology Revolution

1. Bioavailability Breakthroughs

Technology

Principle

Bioavailability Gain

Product Example

Phospholipid Complex

Mimics chylomicron absorption

3.2x ↑

K2Vital® DELIVERY

Nano-Crystals

<200nm particle size

2.5x ↑

NanoK2™

Microencapsulated MK-4

Ethyl cellulose coating

4.1x ↑

MenaQ7® PROTECT

 

 

2. Antioxidant Systems:

   • Mild GI Discomfort: Tocopherol + rosmarinic acid (3-year shelf life)

   • Lyophilization: MK-7 degradation <1%/year at 4°C (Food Chem, 2023)

 

 

———————————————————————————————————————————————————————————————————————————

 

7. Safety & Personalized Dosing

1. Evidence-Based Dosing Matrix

Health Goal

MK-4 Dose

MK-7 Dose

Combination Therapy

Osteoporosis prevention

15-30mg/day

90-120μg/day

+ Calcium 500mg + VD3 2000IU

Arterial calcification reversal

45mg/day (Japan)

180-360μg/day

+ Magnesium 300mg

Anti-aging

Not established

300-500μg/day

+ NR 500mg + Resveratrol

 

2. Contraindications

   • Warfarin users: Stabilize INR before use (K2 antagonizes anticoagulation)

   • Cholestasis patients: Require bile acid supplements (fat-soluble absorption issue)

 

 

———————————————————————————————————————————————————————————————————————————

 

8. Global Market Landscape

1. Regional Consumption

Region

Dominant Form

Market Size (2023)

Growth Rate

Japan

High-dose MK-4

$280M

5.2%

EU/USA

MK-7 supplements

$410M

18.7%

China

Hybrid K2 products

$60M

42.3%

 

2. Future Trends

   • iagnostic Revolution: Osteocalcin carboxylation testing (Quest Labs 2024 launch)

   • Synthetic Biology: Engineered yeast for MK-9 production (70% cost reduction, Nat Biotechnol, 2023)

 

——————————————————————————————————————————————————————————————————————————

 

9. References(Selected)

   • Knapen, M.H.J., et al. (2015). Menaquinone-7 improves arterial stiffnessThromb Haemost.

   • Shiraki, M., et al. (2006). High-dose MK-4 for osteoporosisJ Bone Miner Metab.

   • US 9,987,123High-purity MK-4 isolation.

 

 

If you're interested in Glucoraphanin (GRN) powder into your supplement formulations, please reach out to JX Nutritional Chemical Co., Limited team. We will reply you as soon as possible.

Get In Touch With Us

Security verification
Reset GET A QUOTE/SAMPLE
%{tishi_zhanwei}%